Direct-Fed Microbials Market - Global Forecast to 2022

“Global direct-fed microbials market projected to have a CAGR of 6.96%.”

The global direct-fed microbials market is projected to reach a value of USD 1,399.6 million by 2022, growing at a CAGR of 6.96% from 2016. The demand for direct-fed microbials in animal feed is projected to grow during the forecast period owing to the rapidly increasing global demand for quality animal products. The market is influenced by the growing awareness among consumers about preventive healthcare and nutrition. Factors such as low shelf life and high cost of direct-fed microbials are leading to a rise in the cost of production and restraining the growth of the market.

 “Lactic acid bacteria segment accounted for the largest market share among the types of direct-fed microbials in 2015.”

On the basis of type, direct-fed microbials have been segmented into lactic acid bacteria, bacillus, and others which include prevotella bryantii, live beneficial bacteria, and Propionibacterium. Among these, the lactic acid bacteria segment accounted for the largest share in 2015, followed by the bacillus segment. Lactic acid bacteria are widely used for feed of poultry and ruminants, for healthy growth.

“Poultry segment led the market with the largest share in 2015.”

On the basis of livestock, the direct-fed microbials market has been segmented into swine, ruminants, poultry, aquatic animals, and others which include equine and pets. The market was led by the poultry segment, followed by ruminants. The role of direct-fed microbials in poultry includes altering the metabolism by enhancing digestive enzyme activity, maintaining normal intestinal microflora, and reducing bacterial enzyme activity and ammonia production.

“North America dominated the market with the largest share in 2015.”

North America formed the largest market for direct-fed microbials in 2015, whereas Europe accounted for the second-largest market share in 2015. The application of direct-fed microbials in animal feed is expected to increase at a faster pace in Europe and the Asia-Pacific region due to the rising demand. The farming techniques used in the region require healthy and strong farm animals; direct-fed microbials help in balancing the digestive systems and enhancing the immunity systems of livestock.

Livestock has always been an important industry in the North American agriculture sector and shows a positive future outlook, due to increasing meat exports as well as rising consumption within the country. Canada has the advantage of lower feed cost due to the small biofuel industry, which allows more grain input in livestock breeding.

Breakdown of profiles of primary participants is as follows:

 By Company Type: Tier 1 – 30 %, Tier 2 – 45%, and Tier 3 – 25%

 By Designation: Directors – 22%, C level – 28%, and Manager level – 50%

 By Region: North America – 35%, Europe – 23%, Asia-Pacific – 32%, and RoW – 10%

The key players identified in the global direct-fed microbials market include Archer Daniels Midland Company (U.S.), E. I. du Pont de Nemours and Company (U.S.), Koninklijke DSM N. V. (Netherlands), Novozymes (Denmark), Chr. Hansen A/S (Denmark), Kemin Industries (U.S.), BIOMIN Holding GmbH (Austria), Lallemand Inc. (Canada), Novus International, Inc. (U.S.), and Bio-vet (U.S.).

Research Coverage:

 This study estimates the global market size of direct-fed microbials, in terms of dollar value, till 2022, segmented on the basis of type, livestock, and form.

 It offers a detailed qualitative and quantitative analysis of this market with reference to the competitive landscape and preferred development strategies such as expansions and investments, and to gain a larger share in the market.

 It provides a comprehensive review of major market drivers, restraints, opportunities, challenges, and key issues of the market

Reasons to buy this report:

From an insight perspective, this research report has focused on various levels of analyses—market sizing, industry analysis (industry trends), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape as well as dynamics of the study market.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on direct-fed microbials offered by the top players in the global market

• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the market

• Market Development: Comprehensive information about lucrative emerging markets across various regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global market

• Competitive Assessment: In-depth assessment of market share, strategies, products, and manufacturing capabilities of the leading players in the global market

1 INTRODUCTION 13

1.1 OBJECTIVES OF THE STUDY 13

1.2 MARKET DEFINITION 14

1.3 STUDY SCOPE 14

1.3.1 MARKET COVERED 14

1.3.2 PERIODIZATION 15

1.4 CURRENCY 15

1.5 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17

2.1 INTRODUCTION 17

2.2 RESEARCH DATA 18

2.2.1 SECONDARY DATA 18

2.2.1.1 Key data from secondary sources 18

2.2.2 PRIMARY DATA 19

2.2.2.1 Key data from primary sources 19

2.2.2.2 Key industry insights 20

2.2.2.3 Breakdown of primary interviews 20

2.3 MARKET SIZE ESTIMATION 21

2.3.1 BOTTOM-UP APPROACH 21

2.3.2 TOP-DOWN APPROACH 22

2.4 MARKET BREAKDOWN & DATA TRIANGULATION 23

2.5 RESEARCH ASSUMPTIONS & LIMITATIONS 24

2.5.1 ASSUMPTIONS 24

2.5.2 LIMITATIONS 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 30

4.1 ATTRACTIVE OPPORTUNITIES IN THE DIRECT-FED MICROBIALS MARKET 30

4.2 DIRECT-FED MICROBIALS MARKET, BY LIVESTOCK 31

4.3 LIFE CYCLE ANALYSIS: DIRECT-FED MICROBIALS MARKET, BY REGION 31

4.4 DIRECT-FED MICROBIALS MARKET, BY TYPE 32

4.5 DIRECT-FED MICROBIALS MARKET, BY KEY COUNTRY 33

4.6 DIRECT-FED MICROBIALS MARKET, BY FORM & REGION 34

5 MARKET OVERVIEW 35

5.1 INTRODUCTION 35

5.2 MACROINDICATORS 35

5.2.1 INCREASE IN MEAT PRODUCTION/CONSUMPTION 36

5.2.2 GROWING LIVESTOCK POPULATION 37

5.2.3 PARENT MARKET ANALYSIS: ANIMAL FEED INDUSTRY 38

5.3 MARKET SEGMENTATION 39

5.3.1 BY TYPE 39

5.3.2 BY FORM 40

5.3.3 BY LIVESTOCK 40

5.3.4 BY REGION 41

5.4 MARKET DYNAMICS 42

5.4.1 DRIVERS 43

5.4.1.1 Increasing awareness about animal health 43

5.4.1.2 Rise in global meat and milk consumption 43

5.4.1.3 Increased demand for quality animal products 43

5.4.1.4 Increase in demand for animal protein 44

5.4.2 RESTRAINTS 45

5.4.2.1 Varying regulations pertaining to consumption of bacteria in food and feed 45

5.4.3 OPPORTUNITIES 45

5.4.3.1 Ban on the usage of antibiotic growth promoters (AGP) 45

5.4.3.2 Health benefits for livestock in the wake of rising animal health concerns 46

5.4.4 CHALLENGES 46

5.4.4.1 Increasing cost of production and operations 46

5.5 PARENT MARKET ANALYSIS 47

6 INDUSTRY TRENDS 49

6.1 INTRODUCTION 49

6.2 GLOBAL DIRECT-FED MICROBIALS IN ANIMAL FEED MARKET: SUPPLY CHAIN ANALYSIS 49

6.2.1 INDUSTRY INSIGHTS 50

6.3 DIRECT-FED MICROBIALS IN ANIMAL FEED MARKET: PORTER’S FIVE FORCES ANALYSIS 51

6.3.1 INTENSITY OF COMPETITIVE RIVALRY 52

6.3.2 BARGAINING POWER OF SUPPLIERS 52

6.3.3 BARGAINING POWER OF BUYERS 53

6.3.4 THREAT OF SUBSTITUTES 53

6.3.5 THREAT OF NEW ENTRANTS 53

  DIRECT-FED MICROBIALS MARKET, BY TYPE 54

7.1 INTRODUCTION 55

7.2 LACTIC ACID BACTERIA 56

7.2.1 LACTOBACILLI 56

7.2.1.1 Research on Lactobacilli 56

7.2.2 BIFIDOBACTERIA 57

7.2.2.1 Research on Bifidobacteria 57

7.2.3 STREPTOCOCCUS THERMOPHILUS 57

7.3 BACILLUS SUBTILIS 58

7.3.1 BACILLUS LICHENIFORMIS 59

7.4 OTHER BACTERIA 60

8 DIRECT-FED MICROBIALS MARKET, BY LIVESTOCK 61

8.1 INTRODUCTION 62

8.2 SWINE 64

8.3 POULTRY 65

8.4 RUMINANTS 66

8.5 AQUATIC ANIMALS 67

8.6 OTHERS 68

9 DIRECT-FED MICROBIALS MARKET, BY FORM 69

9.1 INTRODUCTION 70

9.2 DRY FORM 72

9.3 LIQUID FORM 73

10 DIRECT-FED MICROBIALS MARKET, BY REGION 74

10.1 INTRODUCTION 75

10.2 NORTH AMERICA 76

10.2.1 U.S. 80

10.2.2 CANADA 81

10.2.3 MEXICO 83

10.3 EUROPE 84

10.3.1 U.K. 88

10.3.2 GERMANY 89

10.3.3 FRANCE 90

10.3.4 ITALY 91

10.3.5 SPAIN 93

10.3.6 REST OF EUROPE 94

10.4 ASIA-PACIFIC 95

10.4.1 CHINA 97

10.4.2 INDIA 99

10.4.3 JAPAN 100

10.4.4 REST OF ASIA-PACIFIC 101

10.5 REST OF THE WORLD (ROW) 102

10.5.1 LATIN AMERICA 104

10.5.2 MIDDLE EAST AND AFRICA 106

11 COMPETITIVE LANDSCAPE 107

11.1 OVERVIEW 107

11.2 DIRECT-FED MICROBIALS MARKET: COMPANY RANKING 108

11.3 COMPETITIVE SITUATION & TRENDS 109

11.4 EXPANSIONS & INVESTMENTS: THE KEY STRATEGY, 2011–2016 110

11.4.1 EXPANSIONS & INVESTMENTS 111

11.4.2 MERGERS & ACQUISITIONS 112

11.4.3 NEW PRODUCT LAUNCHES 113

11.4.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES 114

12 COMPANY PROFILES 115

12.1 ARCHER DANIELS MIDLAND COMPANY 115

12.2 E.I. DUPONT DE NEMOURS AND COMPANY 118

12.3 KONINKLIJKE DSM N.V. 122

12.4 NOVOZYMES 126

12.5 CHR. HANSEN HOLDING A/S 129

12.6 KEMIN INDUSTRIES, INC. 133

12.7 BIOMIN HOLDING GMBH 135

12.8 LALLEMAND, INC. 137

12.9 NOVUS INTERNATIONAL, INC. 139

12.10 BIO-VET 140

13 APPENDIX 142

13.1 DISCUSSION GUIDE 142

13.1.1 EXPANSIONS & INVESTMENTS 145

13.1.2 MERGERS & ACQUISITIONS 147

13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 148

13.3 AVAILABLE CUSTOMIZATIONS 150

13.4 RELATED REPORTS 151

13.5 AUTHOR DETAILS 152

List Of Tables

TABLE 1 PER CAPITA CONSUMPTION OF MEAT THROUGH 2030 36

TABLE 2 PER CAPITA PROTEIN SUPPLY FOR KEY COUNTRIES, 2006-2009 (GRAMS/DAY) 44

TABLE 3 EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 47

TABLE 4 EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 47

TABLE 5 EUBIOTICS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 48

TABLE 6 INDUSTRY INSIGHTS: LEADING TRENDS AMONG KEY PLAYERS 50

TABLE 7 DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION) 56

TABLE 8 LACTIC ACID BACTERIA MARKET SIZE, BY REGION, 2014-2022 (USD MILLION) 58

TABLE 9 BACILLUS SUBTILIS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION) 59

TABLE 10 OTHER BACTERIA MARKET SIZE, BY REGION, 2014-2022 (USD MILLION) 60

TABLE 11 DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 63

TABLE 12 SWINE: DIRECT-FED MICROBIALS MARKET SIZE, BY REGION,

2014–2022 (USD MILLION) 64

TABLE 13 POULTRY: DIRECT-FED MICROBIALS MARKET SIZE, BY REGION,

2014–2022 (USD MILLION) 65

TABLE 14 RUMINANTS: DIRECT-FED MICROBIALS MARKET SIZE, BY REGION,

2014–2022 (USD MILLION) 66

TABLE 15 AQUATIC ANIMALS: DIRECT-FED MICROBIALS MARKET SIZE, BY REGION,

2014–2022(USD MILLION) 67

TABLE 16 OTHERS: DIRECT-FED MICROBIALS MARKET SIZE, BY REGION,

2014–2022 (USD MILLION) 68

TABLE 17 DIRECT-FED MICROBIALS MARKET SIZE, BY FORM, 2014–2022 (USD MILLION) 71

TABLE 18 DRY DIRECT-FED MICROBIALS MARKET SIZE, BY REGION,

2014–2022 (USD MILLION) 72

TABLE 19 LIQUID DIRECT-FED MICROBIALS MARKET SIZE, BY REGION,

2014–2022 (USD MILLION) 73

TABLE 20 DIRECT-FED MICROBIALS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 75

TABLE 21 NORTH AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY,

2014–2022 (USD MILLION) 78

TABLE 22 NORTH AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 78

TABLE 23 NORTH AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 79

TABLE 24 NORTH AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY FORM,

2014–2022 (USD MILLION) 79

TABLE 25 U.S.: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 80

TABLE 26 U.S.: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 81

TABLE 27 CANADA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 82

TABLE 28 CANADA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 82

TABLE 29 MEXICO: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 83

TABLE 30 MEXICO: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 84

TABLE 31 EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY,

2014–2022 (USD MILLION) 86

TABLE 32 EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 86

TABLE 33 EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 87

TABLE 34 EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY FORM,

2014–2022 (USD MILLION) 87

TABLE 35 U.K.: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 88

TABLE 36 U.K.: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 89

TABLE 37 GERMANY: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 89

TABLE 38 GERMANY: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 90

TABLE 39 FRANCE: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 90

TABLE 40 FRANCE: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 91

TABLE 41 ITALY: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 92

TABLE 42 ITALY: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 92

TABLE 43 SPAIN: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 93

TABLE 44 SPAIN: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 93

TABLE 45 REST OF EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 94

TABLE 46 REST OF EUROPE: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 95

TABLE 47 ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY,

2014–2022 (USD MILLION) 96

TABLE 48 ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 96

TABLE 49 ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 97

TABLE 50 ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY FORM,

2014–2022 (USD MILLION) 97

TABLE 51 CHINA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 98

TABLE 52 CHINA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 98

TABLE 53 INDIA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 99

TABLE 54 INDIA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 100

TABLE 55 JAPAN: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 100

TABLE 56 JAPAN: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 101

TABLE 57 REST OF ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 101

TABLE 58 REST OF ASIA-PACIFIC: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 102

TABLE 59 ROW: DIRECT-FED MICROBIALS MARKET SIZE, BY COUNTRY,

2014–2022 (USD MILLION) 102

TABLE 60 ROW: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 103

TABLE 61 ROW: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 103

TABLE 62 ROW: DIRECT-FED MICROBIALS MARKET SIZE, BY FORM,

2014–2022 (USD MILLION) 103

TABLE 63 LATIN AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 104

TABLE 64 LATIN AMERICA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 105

TABLE 65 MEA: DIRECT-FED MICROBIALS MARKET SIZE, BY TYPE,

2014–2022 (USD MILLION) 106

TABLE 66 MEA: DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2014–2022 (USD MILLION) 106

TABLE 67 EXPANSIONS & INVESTMENTS, 2011–2016 111

TABLE 68 MERGERS & ACQUISITIONS, 2011–2016 112

TABLE 69 NEW PRODUCT LAUNCHES, 2011–2016 113

TABLE 70 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES,

2011–2016 114

TABLE 71 EXPANSIONS & INVESTMENTS, 2011–2016 145

TABLE 72 MERGERS & ACQUISITIONS, 2011–2016 147

List Of Figures

FIGURE 1 DIRECT-FED MICROBIALS MARKET SEGMENTATION 14

FIGURE 2 RESEARCH DESIGN 17

FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 21

FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 22

FIGURE 5 DATA TRIANGULATION 23

FIGURE 6 DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK,

2016 VS. 2022 (USD MILLION) 26

FIGURE 7 LACTIC ACID BACTERIA PROJECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE DIRECT-FED MICROBIALS MARKET FROM 2016 TO 2022 27

FIGURE 8 DRY FORM IS PROJECTED TO DOMINATE THE DIRECT-FED MICROBIALS MARKET THROUGH 2022 28

FIGURE 9 NORTH AMERICA ACCOUNTED FOR THE LARGEST MARKET SHARE FOR DIRECT-FED MICROBIALS IN 2015 29

FIGURE 10 DIRECT-FED MICROBIALS MARKET: AN EMERGING MARKET WITH PROMISING GROWTH POTENTIAL, 2016-2022 30

FIGURE 11 POULTRY ACCOUNTED FOR THE LARGEST SHARE IN THE DIRECT-FED MICROBIALS MARKET, 2016-2022 31

FIGURE 12 DIRECT-FED MICROBIALS MARKET IN NORTH AMERICA IS EXPERIENCING

HIGH GROWTH 31

FIGURE 13 LACTIC ACID BACTERIA IS EXPECTED TO DOMINATE THE MARKET THROUGHOUT THE FORECAST PERIOD 32

FIGURE 14 GERMANY IS PROJECTED TO BE FASTEST-GROWING MARKET, 2016-2022 33

FIGURE 15 EUROPE ACCOUNTED FOR THE LARGEST SHARE IN THE FORM SEGMENT OF THE DIRECT-FED MICROBIALS MARKET IN 2015 34

FIGURE 16 GLOBAL RUMINANTS POPULATION, 2000-2015, BILLION HEADS 37

FIGURE 17 DIRECT-FED MICROBIALS MARKET, BY TYPE 39

FIGURE 18 DIRECT-FED MICROBIALS MARKET, BY FORM 40

FIGURE 19 DIRECT-FED MICROBIALS MARKET, BY LIVESTOCK 40

FIGURE 20 DIRECT-FED MICROBIALS MARKET, BY REGION 41

FIGURE 21 MARKET DYNAMICS SNAPSHOT 42

FIGURE 22 STRAIN DEVELOPMENT AND MARKETING AND SALES PLAY A VITAL ROLE IN THE SUPPLY CHAIN OF DIRECT-FED MICROBIALS IN ANIMAL FEED 49

FIGURE 23 DIRECT-FED MICROBIALS MARKET: PORTER’S FIVE FORCES ANALYSIS 51

FIGURE 24 LACTIC ACID BACTERIA SEGMENT TO BE THE FASTEST-GROWING BY 2022 55

FIGURE 25 DIRECT-FED MICROBIALS MARKET SIZE, BY LIVESTOCK, 2016-2022 63

FIGURE 26 DRY SEGMENT TO DOMINATE THE DIRECT-FED MICROBIALS MARKET

THROUGH 2022 71

FIGURE 27 U.S. ACCOUNTED FOR THE LARGEST SHARE IN THE NORTH AMERICAN DIRECT-FED MICROBIALS MARKET 77

FIGURE 28 EUROPE: DIRECT-FED MICROBIALS MARKET SNAPSHOT 85

FIGURE 29 GLOBAL DIRECT-FED MICROBIALS COMPANY RANKINGS (2015) 108

FIGURE 30 BATTLE FOR MARKET SHARE: EXPANSIONS AND INVESTMENTS WAS THE MOST POPULAR GROWTH STRATEGY 109

FIGURE 31 EXPANSIONS & INVESTMENTS FUELED GROWTH AND INNOVATION (2014–2016) 110

FIGURE 32 ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT 115

FIGURE 33 ARCHER DANIELS MIDLAND COMPANY: SWOT ANALYSIS 117

FIGURE 34 E.I. DUPONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT 118

FIGURE 35 E. I. DU PONT DE NEMOURS AND COMPANY: SWOT ANALYSIS 120

FIGURE 36 KONINKLIJKE DSM N.V. : COMPANY SNAPSHOT 123

FIGURE 37 KONINKLIJKE DSM N. V.: SWOT ANALYSIS 125

FIGURE 38 NOVOZYMES: COMPANY SNAPSHOT 126

FIGURE 39 NOVOZYMES: SWOT ANALYSIS 128

FIGURE 40 CHR. HANSEN A/S: COMPANY SNAPSHOT 129

FIGURE 41 CHR. HANSEN A/S: SWOT ANALYSIS 132

Fill The Form For Sample Request

There is no Reviews available